These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 8795392)

  • 21. Alkali citrate prophylaxis in idiopathic recurrent calcium oxalate urolithiasis--a prospective randomized study.
    Hofbauer J; Höbarth K; Szabo N; Marberger M
    Br J Urol; 1994 Apr; 73(4):362-5. PubMed ID: 8199822
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metabolic risk factors in pediatric and adult calcium oxalate urinary stone formers: is there any difference?
    Tefekli A; Esen T; Ziylan O; Erol B; Armagan A; Ander H; Akinci M
    Urol Int; 2003; 70(4):273-7. PubMed ID: 12740490
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Agglomeration inhibition reflected stone-forming activity during long-term potassium citrate therapy in calcium stone formers.
    Fuselier HA; Moore K; Lindberg J; Husserl FE; Cole FE; Kok DJ; Whitehead D; Galliano DJ; Erwin DT
    Urology; 1998 Dec; 52(6):988-94. PubMed ID: 9836542
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correction of hypocitraturia and prevention of stone formation by combined thiazide and potassium citrate therapy in thiazide-unresponsive hypercalciuric nephrolithiasis.
    Pak CY; Peterson R; Sakhaee K; Fuller C; Preminger G; Reisch J
    Am J Med; 1985 Sep; 79(3):284-8. PubMed ID: 4036979
    [TBL] [Abstract][Full Text] [Related]  

  • 25. On the relation between citrate and calcium in normal and stone-former subjects.
    Conte A; Roca P; Gianotti M; Grases F
    Int Urol Nephrol; 1990; 22(1):7-12. PubMed ID: 2380005
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Idiopathic hypocitraturic calcium-oxalate nephrolithiasis successfully treated with potassium citrate.
    Pak CY; Fuller C
    Ann Intern Med; 1986 Jan; 104(1):33-7. PubMed ID: 3940503
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dietary management of hypocitraturia in children with urolithiasis: results from a systematic review.
    Castellani D; Giulioni C; De Stefano V; Brocca C; Fuligni D; Galosi AB; Teoh JY; Sarica K; Gauhar V
    World J Urol; 2023 May; 41(5):1243-1250. PubMed ID: 36645461
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Citric acid or citrates in urine: which should we focus on in the prevention of calcium oxalate crystals and stones?
    Laube N; Jansen B; Hesse A
    Urol Res; 2002 Oct; 30(5):336-41. PubMed ID: 12389124
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical significance of hypocitraturia in kidney stone patients.
    Matsushita K; Tanikawa K; Masuda A; Matsuzaki S
    Nihon Jinzo Gakkai Shi; 1993 Nov; 35(11):1253-7. PubMed ID: 8139138
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Indication of the urinary citrate levels in idiopathic renal calculosis].
    Jaeger P; Portmann L; Jacquet AF; Burckhardt P
    Schweiz Med Wochenschr; 1986 Mar; 116(12):371-3. PubMed ID: 3961456
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of potassium citrate therapy on stone recurrence and residual fragments after shockwave lithotripsy in lower caliceal calcium oxalate urolithiasis: a randomized controlled trial.
    Soygür T; Akbay A; Küpeli S
    J Endourol; 2002 Apr; 16(3):149-52. PubMed ID: 12028622
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypocitraturia in calcium nephrolithiasis.
    Rudman D; Kutner MH; Redd SC; Waters WC; Gerron GG; Bleier J
    J Clin Endocrinol Metab; 1982 Dec; 55(6):1052-7. PubMed ID: 7130336
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Urinary citrate in kidney stone disease.
    Usui Y; Matsuzaki S; Matsushita K; Shima M
    Tokai J Exp Clin Med; 2003 Jul; 28(2):65-70. PubMed ID: 14714831
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Urine citrate and renal stone disease.
    Goldberg H; Grass L; Vogl R; Rapoport A; Oreopoulos DG
    CMAJ; 1989 Aug; 141(3):217-21. PubMed ID: 2665909
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Citrate in the management of urolithiasis.
    Pattaras JG; Moore RG
    J Endourol; 1999 Nov; 13(9):687-92. PubMed ID: 10608522
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Urinary citrate excretion in normal persons and patients with idiopathic calcium urolithiasis.
    Hosking DH; Wilson JW; Liedtke RR; Smith LH; Wilson DM
    J Lab Clin Med; 1985 Dec; 106(6):682-9. PubMed ID: 4067380
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Urinary risk factors for recurrent calcium stone formation in Thai stone formers.
    Stitchantrakul W; Kochakarn W; Ruangraksa C; Domrongkitchaiporn S
    J Med Assoc Thai; 2007 Apr; 90(4):688-98. PubMed ID: 17487123
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Citrate and recurrent idiopathic calcium urolithiasis. A longitudinal pilot study on the metabolic effects of oral potassium sodium citrate administered as short-, medium- and long-term to male stone patients.
    Herrmann U; Schwille PO; Schwarzlaender H; Berger I; Hoffmann G
    Urol Res; 1992; 20(5):347-53. PubMed ID: 1455567
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alkaline citrate reduces stone recurrence and regrowth after shockwave lithotripsy and percutaneous nephrolithotomy.
    Lojanapiwat B; Tanthanuch M; Pripathanont C; Ratchanon S; Srinualnad S; Taweemonkongsap T; Kanyok S; Lammongkolkul S
    Int Braz J Urol; 2011; 37(5):611-6. PubMed ID: 22099273
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alkali citrate for preventing recurrence of calcium oxalate stones.
    Hauser W; Frick J; Kunit G
    Eur Urol; 1990; 17(3):248-51. PubMed ID: 2190842
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.